FDAReview.org

Breakthrough Alzheimer’s Drug Puts FDA’s Drug-Approval Process into Question

Raymond March - October 29, 2019

Is Right-to-Try Legislation a Bust? Time for a Second Opinion.

October 17, 2019

Trust Walmart’s Insulin to Save Lives

August 27, 2019

FDA Investigates Supposed Link Between Vaping and Seizures

August 20, 2019

What's New

How Government Prolonged the Lobotomy

Raymond March - August 19, 2019

New Study Finds FDA in Contempt of the U.S. Constitution

Raymond March - August 1, 2019

Worried About Big Pharma? Then Reduce the FDA’s Regulatory Power.

Raymond March - July 29, 2019

As Insulin Prices Rise, Diabetics Turn to Black Markets

Raymond March - July 9, 2019

San Francisco’s Vaping Ban Is Doomed To Go Up in Smoke

Raymond March - July 3, 2019

Right-to-Try Legislation Helps Patient Battling Bone Cancer

Raymond March - June 24, 2019

FDA Approves $2 Million Drug. Blame the Price on Excessive Regulation.

Raymond March - May 30, 2019

FDA To Stop Regulating the Amount of Cherries in Frozen Cherry...

Raymond March - May 15, 2019

Political Rhetoric Against Right-to-Try Laws Continues, Undermining Support for Medical Treatments...

Raymond March - May 7, 2019

FDA Approves Ketamine-Based Drug to Treat Difficult Cases of Depression

March 28, 2019

Generic Insulin Now Available After Nearly One Hundred Years of Regulatory...

March 25, 2019

FDA Wants More Sunscreen Regulations, but Would Consumers Get Burned?

March 14, 2019

FDA Panel Backs Ketamine-Based Treatment for Depression

March 1, 2019